INTRODUCTION {#s1}
============

Two randomized controlled trials (RCTs) testing the supposed benefits of haemodiafiltration (HDF) on survival observed such beneficial effects only in a *post hoc* analysis when convection volumes were high (\>17 or 22 L following the studies) \[[@gfw370C1], [@gfw370C2]\]. In a third RCT by Maduell *et al.* \[[@gfw370C3]\], applying high convection as the treatment of choice was associated with observed a significant improvement in survival over classical high-flux dialysis. These reports and subsequent confirmatory work have definitely influenced the opinion of the renal community, and the belief is growing that post-dilutional online HDF (OL-HDF) with high convection volumes(HC-HDF) is the best treatment, at the present time, to improve patient\'s survival prospects \[[@gfw370C4], [@gfw370C5]\].

High convection volumes can be obtained only with high-flux/highly permeable dialyzers and require increased transmembrane pressure (TMP). During the treatment procedure, particularly when high convection is requested, fouling of the membrane may occur, altering the efficacy of the system \[[@gfw370C6]\] and provoking a sustained increase of the TMP necessary to obtain the requested volumes. This results in alarms and system instability. Some attempts have been made to control this situation, and several systems automatically decrease the ultrafiltration flow when TMP is considered too high \[[@gfw370C6]--[@gfw370C12]\]. Dialysis stability is then obtained at the price of decreasing the total convection volume below that initially prescribed, without informing the physician in charge of the treatment. Therefore, new approaches to increase the stability of the system and minimize its deviation in terms of water permeability are needed.

The recently described ~G~K~D-UF~ and ~G~K~D-UF~-max \[[@gfw370C13]\] are promising parameters to support maintaining the system at its optimal filtration conditions. ~G~K~D-UF~ follows a parabolic function when increasing convection flow, defining a maximum level of ~G~K~D-UF~, which is the vertex of the parabola. The Q~UF~ at which ~G~K~D-UF~-max is observed is the highest ultrafiltration flow obtained per TMP unit in that system \[[@gfw370C14]\].

Since ~G~K~D-UF~ is an objective parameter of the water permeability of a dialysis system, it can be used to monitor convection flow and help in identifying any potential diversion of the system during the treatment procedure when high convective volumes are requested.

To deepen our understanding of this parameter, we assessed the reproducibility of ~G~K~D-UF~, ~G~K~D-UF~-max and its associated Q~UF~ and observed that these parameters are accurate and reproducible enough to be used in clinics.

MATERIALS AND METHODS {#s2}
=====================

Patients {#s2a}
--------

Fifteen stable dialysis patients treated in the dialysis centre of Néphrologie Dialyse St Guilhem in Sète (France) were included in the study (Table 1). They were dialyzed three times a week with online HDF Dialog+ (BBraun, Melsungen, Germany) and DBB 07 (NIKKISO, Tokyo, Japan) machines, using ultrapure double reverse osmosis water. Their vascular accesses were native arteriovenous fistulas (14 patients) and jugular catheters (1 patient). They had been on dialysis for \>3 months and had no active disease during the study. They were able to understand the study and gave signed informed consent to participate in it. The study protocol was approved by the Comité de Protection des Personnes of Nîmes (2011.10.05 bis; registration number at the French Agency AFSSAPS 2011-A01092-39).

Polysulfone high-flux dialyzers (Xevonta Hi 18, Amembris and Diacap Hips 18, 1.8 m^2^, B Braun Avitum, Melsungen, Germany) were used. Total dialysate production flow was checked for every dialysis monitor and set at 600 mL/min in post-dilution. In pre-dilution; it was set at 500 mL/min plus the infusion flow (maximum 700 mL/min).

Convection flows assessed {#s2b}
-------------------------

~G~K~D-UF~ was determined for all patients at increasing convection flows. To establish ~G~K~D-UF~-max, the infusion flow rate was set at 0 mL/min and then modified stepwise by 10 mL/min from 50 to 100 or 110 mL/min. After ∼1-min stabilization, TMP was recorded and ~G~K~D-UF~ was calculated with Q~UF~: $$Q_{UF} = \text{infusion}\mspace{180mu}\,\text{flow}({{mL}.\min}^{- 1}) + {{weight}\,{loss}}({{mL}.\min}^{- 1})$$$$G_{\,}K_{D - {UF}}(\text{mL}/\text{h}/\text{mmHg}) = Q_{UF}x60\text{/TMP}$$

To prevent excess haemoconcentration in post-dilution, the last step was limited to a Q~UF~ value of 30% of the blood flow (Qb). The vertex of the parabolic function (~G~K~D-UF~/Q~UF~) is ~G~K~D-UF~-max. The corresponding total convection flow is ~G~K~D-UF~-max associated Q~UF~ (and corresponds to the x value of the ~G~K~D-UF~-max point). A specific software was developed to quickly determine ~G~K~D-UF~-max and its associated Q~UF~ at bedside.

TMP was given by the dialysis machines with three (B BRAUN Dialog+) or four (NIKKISO DBB 07) pressure sensors. The pressure sensors to assess TMP were located at the inlet and outlet of the blood side, the outlet of the dialysate side of the dialyser and, in the case of four-point readings, the dialysate inlet (Figure [1](#gfw370F1){ref-type="fig"}B). In order to increase the accuracy of TMP measurements and standardize them, *in vitro* experiments were performed. FIGURE 1Methods and results of K~UF~ and ~G~K~D-UF~-max determinations. (**A** and **B**) Schematics of the setting to determine K~UF~. (**A**) The *in vitro* setting proposed by the FDA \[15, 16\] to assess K~UF~ for high-permeability dialyzers. It is an isolated ultrafiltration system (with no dialysate), where K~UF~ is determined by the slope of Q~UF~/TMP points (see **C**). (**B**) The *in vivo* setting presently used in clinics, which is closed with an ultrafiltration controller (balancing chambers). (**C**) Q~UF~ increases linearly with TMP in isolated ultrafiltration, the *in vivo* K~UF~ of the dialyzer is the slope of this line (K~UF~ = 1.414 × 60 = 85 mL/h/mmHg) (open squares). The straight line is shifted to the right and parallel when introducing a dialysate flow (same slope and therefore same K~UF~ according to Keshaviah\'s calculations). The shift may be explained, at least in part, by the hydrostatic pressure linked to dialysate flow and the oncotic pressure modifications linked to blood flow. When measurements of Q~UF~ higher than those proposed by Keshaviah\'s were performed, the Q~UF~--TMP relationship no longer followed a straight line function. It bent and tended to plateau. (D) Plotting the values of ~G~K~D-UF~ (Q~UF~/TMP)/Q~UF~ for these *in vivo* measurements described the parabolic distribution of ~G~K~D-UF~. The vertex of the parabola is ~G~K~D-UF~-max and the corresponding Q~UF~ is the highest Q~UF~ that can be obtained for the minimal TMP.

The *in vitro* studies consisted in putting the dialysate tubing in an open volume (a laboratory plastic beaker, at the same height as the dialyzer where pressure = 0) and reading the measurements of the monitor for TMP. A correction factor for each machine could then be obtained, which was the deviation of the TMP readout of the machine from zero during these calibration studies. Following these studies, we decided to incorporate our correction factor to correct the readouts given by the machines during ~G~K~D-UF~ determinations at bedside.

All pressures were measured outside the dialyzer, and the resultant given by the dialysis monitor was corrected as described to obtain the TMP value. Although the precise values of hydrostatic and oncotic pressures whithin the dialyzer are not determined, they are incorporated in the TMP readings. As a result, the parabolic function between Q~UF~ and ~G~K~D-UF~ holds true regardless of the oncotic pressure or haematocrit levels, which influence the absolute value of the vertex but not the shape of the curve.

Statistics {#s2c}
----------

Statistical analyses were performed using SAS 9.2 (SAS, Cary, NC, USA). P-values \<0.05 were considered significant. Values are given as mean ± standard error of the mean (SEM).

RESULTS {#s3}
=======

Parabolic distribution of the ~G~K~D-UF~ and Q~UF~ relationship in high-flux settings with ultrafiltration control {#s3a}
------------------------------------------------------------------------------------------------------------------

The ~G~K~D-UF~ determinations were repeatedly performed at the beginning of dialysis sessions in 15 patients. The parabolic distribution of ~G~K~D-UF~ was systematically observed with high correlation indexes (*R*^2^ = 0.995 ± 0.001 *N* = 150 determinations). The worst fit that was observed had an *R*^2^ value of 0.958 and the best was 0.999. The parabolic function held true in both post-dilutional and pre-dilutional HDF. Figure [1](#gfw370F1){ref-type="fig"} shows the schematics of the setting to measure K~UF~*in vitro* (Figure [1](#gfw370F1){ref-type="fig"}A) and *in vivo* with an ultrafiltration controller (Figure [1](#gfw370F1){ref-type="fig"}B). In isolated ultrafiltration (Figure [1](#gfw370F1){ref-type="fig"}C), the P/Q Q~UF~ over TMP function describes a straight line when limited to 50 mL/min (the US Food and DRug Administration proposes 30 mL/min \[[@gfw370C15]\]), the slope of which is K~UF~ based on Keshaviah *et al.* \[[@gfw370C17]\]. Adding a dialysate flow shifted the straight line to the right and increasing the filtration rate bent the line towards a plateau (Figure [1](#gfw370F1){ref-type="fig"}C). Finally, when ~G~K~D-UF~ was calculated and plotted over Q~UF~, the parabolic function appeared with its vertex, ~G~K~D-UF~-max (Figure [1](#gfw370F1){ref-type="fig"}D).

Reproducibility and variability of ~G~K~D-UF~-max and its associated Q~UF~: {#s3b}
---------------------------------------------------------------------------

### Reproducibility for a given patient {#s3b1}

~G~K~D-UF~-max and its related Q~UF~ were reproducible within a dialysis session. ~G~K~D-UF~ showed a coefficient of variation (CV) of 1.9 ± 0.7% when consecutively determined at the beginning of the dialysis session and 1.0 ± 0.3% at the end of the dialysis session (Figure [2](#gfw370F2){ref-type="fig"}A). The reproducibility of ~G~K~D-UF~-max associated Q~UF~ was good, with CVs of 1.3 ± 0.6 and 2.3 ± 0.2% at the beginning and end of the dialysis session, respectively (Figure [2](#gfw370F2){ref-type="fig"}A). FIGURE 2~G~K~D-UF~-max and Q~UF~ at ~G~K~D-UF~-max reproducibility. (**A**) ~G~K~D-UF~ was consecutively determined three times at the initiation and just before the end of the dialysis session in three patients. The coefficient of variation (CV) was calculated for each patient and the mean ± SEM of individual CVs is plotted. It can be observed that coefficients of variation the CV was \<3%. The variability of the measure of the value of ~G~K~D-UF~-max decreased with the dialysis session, whereas the variability of the Q~UF~ at which ~G~K~D-UF~-max is obtained was remarkably low at the beginning. (**B**) The points represent the mean of a minimum of four ~G~K~D-UF~ measures for 12 patients and the bars are the SEM. The measurements were performed at the beginning of the first session of the week during four consecutive weeks. The blood flow was 370 ± 33 mL/min (mean ± SD), with a range of 300--400 mL/min. It can be observed that the cross-patient variation may be important (\>30%), while the values observed for a given patient are in a narrow range (small SEM lines).

~G~K~D-UF~-max and its related Q~UF~ determined at the initiation of dialysis were reproducible from one dialysis session to the following one for every patient (Figure [2](#gfw370F2){ref-type="fig"}B). The average CV for ~G~K~D-UF~-max was 3.9 ± 0.6% (highest 6.7%). The average CV for ~G~K~D-UF~-max associated Q~UF~ was even lower (3.3 ± 0.3%; highest 5.1%; table in Figure [2](#gfw370F2){ref-type="fig"}B).

### Variability across patients {#s3b2}

~G~K~D-UF~-max varied across patients, from 31 to 42 mL/h^−1^/mmHg (36% increase; Figure [2](#gfw370F2){ref-type="fig"}B). ~G~K~D-UF~-max associated Q~UF~ ranged from 82 to 100 mL/min (22% increase; Figure [2](#gfw370F2){ref-type="fig"}B).

Factors influencing ~G~K~D-UF~-max and its associated Q~UF~: {#s3c}
------------------------------------------------------------

### Patient characteristics {#s3c1}

Across patients, the mean ~G~K~D-UF~-max was negatively associated with plasma protein concentration (Spearman *ρ* = −0.77; P = 0.004), haematocrit (*ρ* = −0.63; P = 0.03) and haemoglobin (*ρ* = −0.58; P = 0.04).[](#gfw370TB1){ref-type="table"}Table 1Patient characteristicsCharacteristicsPatients (*N* = 15)Sex ratio8 males/7 femalesAge (years), mean ± SEM73 ± 12Body weight after dialysis (kg), mean ± SEM71 ± 2Serum proteins (g/L), mean ± SEM62.8 ± 1.2Haematocrit (%), mean ± SEM35.5 ± 1.4Haemoglobin (g/dL), mean ± SEM11.1 ± 0.3Initial renal disease, *n* Diabetic nephropathy4 Glomerulonephritis2 Nephroangiosclerosis3 Polycystic renal disease2 Other/unknown4Vascular access, *n* Native arterio-venous fistula14 Jugular catheter1Blood flow (mL/min), mean ± SEM373 ± 8

### Time of dialysis session {#s3c2}

The ~G~K~D-UF~ parabola assessed at the start of the dialysis session was repeated after 1 and 3 h of dialysis, showing a significant decrease in ~G~K~D-UF~-max both during haemodialysis and HDF (P \< 0.001 for both; Figure [3](#gfw370F3){ref-type="fig"}A). More importantly, this decrease affected the absolute value of ~G~K~D-UF~-max more than the associated Q~UF~. Correlation studies showed that the ~G~K~D-UF~-max change was significantly correlated to weight loss (*R*^2^ = 0.65; P \< 0.001; Figure [3](#gfw370F3){ref-type="fig"}B). These data show that variations in ~G~K~D-UF~ during the dialysis session are patient dependent. FIGURE 3Mean ~G~K~D-UF~-max variations during the treatment. (**A**) The influence of the dialysis technique and time on ~G~K~D-UF~-max. The same patients were treated with either haemodialysis (HD) or HDF. ~G~K~D-UF~ was measured at the beginning of the treatment and at 60 and 180 min; HD and HDF are plotted. The absolute value of ~G~K~D-UF~-max decreased during the treatment and, although not significantly different, there was a trend towards a greater decrease for HDF. (**B**) The influence of body weight loss on ~G~K~D-UF~-max variation during dialysis. The change in ~G~K~D-UF~-max (% difference of initial and 180 min) was significantly correlated with body weight loss\] in percentage of total body weight; *R*^2^ = 0.65 (P \< 0.001)\], showing that patient factors (among which, probably refilling) influence the decrease of ~G~K~D-UF~-max during the dialysis session.

### Blood flow and infusion site {#s3c3}

For six patients, ~G~K~D-UF~-max was determined in four different conditions (pre- and post-dilution HDF each with 250 and 400 mL/min blood flows). The parabolic shape was always observed. Increasing blood flow significantly increased ~G~K~D-UF~-max and its associated Q~UF~ in post-dilution HDF, whereas the opposite was observed in pre-dilution (Figure [4](#gfw370F4){ref-type="fig"}). FIGURE 4Effect of blood flow and infusion site on ~G~K~D-UF.~ The upper panels display the measurements of ~G~K~D-UF~ in a patient treated with two different blood flows \[Qb = 250 mL/min (full squares) and Qb = 400 mL/min (open diamonds)\] and using two different infusion sites \[post-dilution (left-hand side) and pre-dilution (right-hand side)\]. The lower panels show the effect of increasing blood flow on ~G~K~D-UF~-max and its associated Q~UF~. Both significantly increased in post-dilution HDF (left-hand side), while they decreased in pre-dilution HDF(right-hand side) (*N* = 6 and P \< 0.05 for all), although to a lesser extent.

DISCUSSION {#s4}
==========

Determining ~G~K~D-UF~-max is a new method to assess the convection characteristics of a dialysis system that is more adapted to the presently used technology (high convection flows, high-permeability dialysers, closed ultrafiltration circuit and ultrafiltration controllers) \[[@gfw370C13]\] than the ones advised by certain regulatory authorities \[[@gfw370C16]\], which were designed for low-permeability dialyzers and open systems \[[@gfw370C17]\].

Establishing the value of ~G~K~D-UF~-max and its associated Q~UF~ at the beginning of the dialysis procedure provides an objective method to identify the best situation in terms of convection individually for every patient. Since it is a global measure *in vivo* \[[@gfw370C13]\], it takes into account all the parameters known to modulate ultrafiltration internally, alongside the dialyzer (haematocrit, total protein and elicited oncotic pressure) \[[@gfw370C18]\]. By determining ~G~K~D-UF~-max, one can identify the setting with the highest convection for the minimal TMP constraints.

Given the instability observed when requesting very high ultrafiltration flows, the use of ~G~K~D-UF~-max in clinics is promising to minimize the increase in TMP and consequent alarms while maintaining a high ultrafiltration flow. However, before the expected contribution of ~G~K~D-UF~-max to high-flux haemodialysis and HDF is proved, it was important to address the reproducibility and/or variability of the method, as well as the factors influencing this variability. The present work provides all this information and shows that determining ~G~K~D-UF~ is easily performed, reliable, reproducible and has very low coefficients of variation. It is patient-specific, showing that the convection characteristics of a dialysis system may vary by a patient effect, and indeed stresses the value of a personalized prescription of convection. It further shows that the parabolic function also holds true in pre-dilution HDF. The opposite effect on ~G~K~D-UF~ following the increase in blood flow observed in pre- and post-dilution HDF, while maintaining the same infusion flow, is certainly influenced by variations in viscosity \[[@gfw370C19]\] at the dialyzer entrance (an increase in blood flow in pre-dilution results in an increase in viscosity by changing the volume/volume blood--infusate proportion, thereby decreasing ~G~K~D-UF~). While this explains the observed decrease in water permeability, it does not indicate total removal efficacy of the system, which is decreased in pre-dilution HDF \[[@gfw370C20]\].

The values of convection obtained in post-dilution at ~G~K~D-UF~-max in the example given in Figure [4](#gfw370F4){ref-type="fig"} were ∼80 mL/min when Qb was 400 mL/min (20% blood processed), whereas they were 62 mL/min when Qb was 250 mL/min (25% blood processed). These results may be somewhat lower than those usually obtained with automated systems \[[@gfw370C9], [@gfw370C11], [@gfw370C12]\]. If the target convection volume (or flow) is higher than that obtained in the ~G~K~D-UF~-max situation in a given setting, it is possible for the prescriber to increase the dialyzer surface area, to change the dialyzer and/or, if the patient is treated with post-dilution HDF and the vascular access allows it, to increase blood flow (as shown in Figure [4](#gfw370F4){ref-type="fig"}). Doing so, the dialysis system can be maintained in the ~G~K~D-UF~-max situation while allowing higher convection volumes. Alternatively, prescribers may want to obtain the aimed convection volume by setting the system at a Q~UF~ exceeding that of the ~G~K~D-UF~-max. Determining ~G~K~D-UF~ still informs the prescriber on the level of pressure constraints the system will undergo to obtain the prescribed convection volume. Using ~G~K~D-UF~ determinations is a completely different approach than limiting the convection to be prescribed (or obtained) to a percentage of blood flow or imposing a TMP threshold that may be used by other automated systems. We would propose to measure ~G~K~D-UF~ at the beginning of the session to use the value for prescription. The physician will prescribe at the ~G~K~D-UF~-max, or lower or even higher than ~G~K~D-UF~-max, and subsequently ~G~K~D-UF~ determinations may be repeated at any time during the dialysis session to identify any modification appearing during the treatment time.

In presently used clinical settings, determining ~G~K~D-UF~ is a promising tool guiding how to increase convection volume while maintaining system stability as long as possible. ~G~K~D-UF~ is the first objective parameter that has been proved to be applicable to both pre- and post-dilution HDF. Thus it may be of assistance for physicians prescribing high convection post-dilution HDF as well as for those aiming to further increase convection volume using pre-dilution HDF. Finally, ~G~K~D-UF~ may also be of assistance to describe the convective characteristics of a dialysis system very much in line with what is required by the regulatory bodies (FDA, EMA).
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